Comparison of factors | No. of local recurrence (%) | Univariate analysis |
---|---|---|
p valueb | ||
All patients (n = 40) | ||
Timing of denosumab | ||
 Preoperative only | 6/21 (28.6%) | p = 0.719 |
 Postoperative only | 2/9 (22.2%) | |
Timing of denosumab | ||
 Both pre- and postoperative | 0/10 (0.0%) | p = 0.068 |
 Pre- or postoperative only | 8/30 (26.7%) | |
Preoperative (n = 31) | ||
Times of denosumab administration | ||
 5> | 5/7 (71.4%) | p < 0.001 |
 5≦ | 1/24 (4.2%) | |
 Timing of denosumab | ||
 Preoperative only | 6/21 (28.6%) | p = 0.060 |
 Both pre- and postoperative | 0/10 (18.9%) | |
Postoperative (n = 19) | ||
 Times of denosumab administration | ||
 5> | 0/7 (0.0%) | p = 0.253 |
 5≦ | 2/12 (16.7%) | |
Embolization before surgery | ||
 Postoperative only | 2/9 (22.2%) | p = 0.115 |
 Both pre- and postoperative | 0/10 (0.0%) |